Lasse Hjort Jakobsen and Jorne Biccler are attending ASH in December with an oral presentation.
Lasse:
Normalization of Survival and No Relapses after One Year in Adult Burkitt Lymphoma Patients Treated with Intensive Immunochemotherapy: An International Study of 159 Real-World Patients
Jorne:
Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients – a Nordic Lymphoma Group Study of 2,582 Patients